General (Tables)

3 Months Ended

Mar. 31, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

Derivative instruments measured at fair value and their classification in the condensed consolidated balance sheets are presented in the following table (in thousands):

 

	Assets (liabilities) as of March 31, 2026 (unaudited)				Assets (liabilities) as of December 31, 2025
	Notional Amount		Fair Value		Notional Amount		Fair Value
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in prepaid expenses and other short-term assets	$	133,410	$	21,989	$	187,767	$	21,605
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in accrued expenses and other short-term liabilities	$	57,910	$	(308)	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in long-term other assets	$	—	$	—	$	123,959	$	6,465
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in long-term other liabilities	$	152,331	$	(2,063)	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in prepaid expenses and other short-term assets	$	128,535	$	706	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in accrued expenses and other short-term liabilities	$	—	$	—	$	128,132	$	(2,515)
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in long-term other assets	$	160,081	$	2,456	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in long-term other liabilities	$	—	$	—	$	185,688	$	(1,691)

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income

Net gains (losses) related to cash flow hedges that were reclassified from accumulated other comprehensive income to the condensed consolidated statements of operations are presented in the following table (in thousands):

	Three Months Ended
	March 31,
	2026		2025
	(unaudited)
Revenues	$	(668)	$	579
Cost of revenues	80		(192)
Research and development	4,728		(736)
Sales and marketing	152		(481)
General and administrative	1,385		(196)
Financial income, net	229		364
Total net gain (loss) related to cash flow hedges	$	5,906	$	(662)

Schedule of Cash, Cash Equivalents and Investments

Cash equivalents and marketable securities consist of the following (in thousands):

 

	As of March 31, 2026
	(unaudited)
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Cash equivalents
Money market funds	$	89,365	$	—	$	—	$	89,365
Total	$	89,365	$	—	$	—	$	89,365
Marketable securities
US Treasury securities	$	567,961	$	461	$	(232)	$	568,190
Total	$	567,961	$	461	$	(232)	$	568,190
Long-term marketable securities
US Treasury securities	$	113,997	$	—	$	(383)	$	113,614
Total	$	113,997	$	—	$	(383)	$	113,614

	As of December 31, 2025
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Cash equivalents
Money market funds	$	120,155	$	—	$	—	$	120,155
Total	$	120,155	$	—	$	—	$	120,155
Marketable securities
US Treasury securities	$	679,959	$	1,267	$	(1)	$	681,225
Total	$	679,959	$	1,267	$	(1)	$	681,225
Long-term marketable securities
US Treasury securities	$	186,971	$	231	$	—	$	187,202
Total	$	186,971	$	231	$	—	$	187,202